RhumbLine Advisers’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.3M | Buy |
|
|||||
|
2023
Q4 | $1.3M | Sell |
|
|||||
|
2023
Q3 | $1.03M | Buy |
|
|||||
|
2023
Q2 | $1.13M | Buy |
|
|||||
|
2023
Q1 | $1.19M | Buy |
|
|||||
|
2022
Q4 | $1.1M | Buy |
|
|||||
|
2022
Q3 | $1.21M | Buy |
|
|||||
|
2022
Q2 | $798K | Buy |
|
|||||
|
2022
Q1 | $405K | Buy |
|
|||||
|
2021
Q4 | $423K | Sell |
|
|||||
|
2021
Q3 | $1.5M | Buy |
|
|||||
|
2021
Q2 | $1.58M | Sell |
|
|||||
|
2021
Q1 | $1.96M | Sell |
|
|||||
|
2020
Q4 | $2.72M | Buy |
|
|||||
|
2020
Q3 | $2.4M | Sell |
|
|||||
|
2020
Q2 | $3.42M | Buy |
|
|||||
|
2020
Q1 | $1.19M | Buy |
|
|||||
|
2019
Q4 | $1.63M | Buy |
|
|||||
|
2019
Q3 | $763K | Buy |
|
|||||
|
2019
Q2 | $366K | Buy |
|
|||||
|
2019
Q1 | $263K | Sell |
|
|||||
|
2018
Q4 | $241K | Buy |
|
|||||
|
2018
Q3 | $289K | Sell |
|
|||||
|
2018
Q2 | $301K | Buy |
|